Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis

Journal of Dairy Research

Volumn 75, Issue 3, 2008, Pages 310-318

  Poutrel, Bernard ^a   Stegemann, Michael R ^b   Roy, Olivier ^c   Pothier, Francis ^d   Tilt, Nicola ^b   Payne Johnson, Mark ^b  

^a UR1282   (France)

^b ZOETIS   (United States)

^c CEBIPHAR   (France)

^d NONE   (France)

Author keywords

Bovine; Danofloxacin; Escherichia coli; Mastitis; Systemic; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; DANOFLOXACIN; QUINOLONE DERIVATIVE;

ACUTE DISEASE; ANIMAL; ANIMAL DISEASE; ARTICLE; BODY TEMPERATURE; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HISTORY; INFLAMMATION; MILK; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SECRETION; STANDARD; TIME;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; BODY TEMPERATURE; CATTLE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HISTORY, ANCIENT; INFLAMMATION; LEAST-SQUARES ANALYSIS; MASTITIS, BOVINE; MILK; TIME FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS; BOVINAE; ESCHERICHIA COLI;

EID: 48749083630     PISSN: 00220299     EISSN: 14697629     Source Type: Journal    
DOI: 10.1017/S0022029908003348     Document Type: Article

References (29)

1. Burvenich C, Van Merris V, Mehrzad J, Diez-Fraile A & Duchateau L 2003 Severity of E. coli mastitis is mainly determined by cow factors. Veterinary Research 34 521-564
2. Cebra CK, Garry FB & Dinsmore RP 1996 Naturally occurring acute coliform mastitis in Holstein cattle. Journal of Veterinary Internal Medicine 10 252-257
3. Craven N 1991a Antibiotic therapy for control of mastisis. Economic aspects. Societe Francaise de Buiâtzie, pp. 107-118
4. Craven N 1991b Antibiotic therapy in mastitis control. Economics and future prospects. Mammites des vaches laitières. Paris 18-19 décembre 1991 107-118
5. Dosogne H, Meyer E, Sturk A, van Loon J, Massart-Leen AM & Burvenich C 2002 Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis. Inflammation Research 51 201-205
6. Erskine RJ, Bartlett PC, VanLente JL & Phipps CR 2002 Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. Journal of Dairy Science 85 2571-2575
7. Erskine RJ, Tyler JW, Riddell Jr. MG & Wilson RC 1991 Theory, use, and realities of efficacy and food safety of antimicrobial treatment of acute coliform mastitis. Journal of the American Veterinary Medicine Association 198 980-984
8. Grandemange E & Davot J 2002 Field evaluation of the efficacy of marbofloxacin in the treatment of acute mastitis due to Gram-negative bacteria in the dairy cow. Cattle Practice 10 57-62
9. Hill AW & Shears AL 1979 Recurrent coliform mastitis in the dairy cow. Veterinary Record 105 299-301
10. Hill AW, Shears AL & Hibbitt KG 1978 The elimination of serum-resistant Escherichia coli from experimentally infected single mammary glands of healthy cows. Research in Veterinary Science 25 89-93
11. Hoeben BD, Monfardini E, Burvenich C & Hamann J 2000 Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: effect on clinical signs and chemiluminescence of circulating neutrophils. Journal of Dairy Research 67 485-502
12. Hogan J & Smith LK 2003 Coliform mastitis. Veterinary Research 34 507-519
13. Jones GF & Ward GE 1990 Evaluation of systemic administration of gentamicin for treatment of coliform mastitis in cows. Journal of the American Veterinary Medicine Association 197 731-735
14. Kutila T, Suojala L, Lehtolainen T, Saloniemi H, Kaartinen L, Tahti M, Seppala K & Pyörälä S 2004 The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis. Journal of Veterinary Pharmacology and Theriology 27 197-202
15. Lohuis JA, Schukken YH, Verheijden JH, Brand A & Van Miert AS 1990 Effect of severity of systemic signs during the acute phase of experimentally induced Escherichia coli mastitis on milk production losses. Journal of Dairy Science 73 333-341
16. Pyörälä S, Kaartinen L, Kack H & Rainio V 1994 Efficacy of two therapy regimens for treatment of experimentally induced Escherichia coli mastitis in cows. Journal of Dairy Science 77 453-461
17. Pyörälä SH & Pyörälä EO 1998 Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995). Journal of the American Veterinary Medicine Association 212 407-412
18. Rantala M, Kaartinen L, Valimaki E, Stryrman M, Hiekkaranta M, Niemi A, Saari L & Pyörälä S 2002 Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. Journal of Veterinary Pharmacology and Theriology 25 251-258
19. Riollet C, Rainard P & Poutrel B 2000 Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus. Clinical Diagnostics and Laboratory Immunology 7 161-167
20. Sandholm M, Kaartinen L & Pyörälä S 1990 Bovine mastitis - why does antibiotic therapy not always work? An overview. Journal of Veterinary Pharmacology and Theriology 13 248-260
21. Schneider M, Valle M, Woehrle F & Boisrame B 2004 Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. Journal of Dairy Science 87 202-211
22. Serieys F, Raguet Y, Goby L, Schmidt H & Friton G 2005 Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. Journal of Dairy Science 88 93-99
23. Shem-Tov M, Rav-Hon O, Ziv G, Lavi E, Glickman A & Saran A 1998 Pharmacokinetics and penetration of danofloxacin from the blood into the milk of cows. Journal of Veterinary Pharmacology and Theriology 21 209-213
24. Shpigel NY, Levin D, Winkler M, Saran A, Ziv G & Bottner A 1997 Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. Journal of Dairy Science 80 318-323
25. Vancutsem PM, Babish JG & Schwark WS 1990 The fluoroquinolone antimicrobials : structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Veterinarian 80 173-186
26. Vangroenweghe F, Duchateau L & Burvenich C 2004 Moderate inflammatory reaction during experimental Escherichia coli mastitis in primiparous cows. Journal of Dairy Science 87 886-895
27. VICH 2001 International Co-operation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products, Good Clinical Practice, June 2000 effective 01 July 2001. Available from http://www.emea. europa.eu/pdfs/vet/vich/059598en.pdf
28. Wenz JR, Barrington GM, Garry FB, McSweeney KD, Dinsmore RP, Goodell G & Callan RJ 2001 Bacteremia associated with naturally occuring acute coliform mastitis in dairy cows. Journal of the American Veterinary Medicine Association 219 976-981
29. Ziv G 1980 Practical pharmacokinetic aspects of mastitis therapy - 2: practical & therapeutic applications. Veterinary Medicine Small Animal Clinic 75 469-474